Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease
Mir Hilal Ahmad, Mahino Fatima, Mansoor Ali, et al.
Neuropharmacology (2021) Vol. 201, pp. 108831-108831
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 77
SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research—Old Practice for New Trends
Octavian Costin Ioghen, Laura Cristina Ceafalan, Bogdan Popescu
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 65
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 27
Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms
Julia Anchimowicz, Piotr Zielonka, Sławomir Jakieła
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 380-380
Open Access | Times Cited: 3
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Yumin Wang, Luyan Gao, Jichao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 75
Advances made in removing paraquat herbicide by adsorption technology: A review
Dison S.P. Franco, Jordana Georgin, Éder C. Lima, et al.
Journal of Water Process Engineering (2022) Vol. 49, pp. 102988-102988
Closed Access | Times Cited: 58
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Closed Access | Times Cited: 48
The neuroprotective mechanisms of naringenin: Inhibition of apoptosis through the PI3K/AKT pathway after hypoxic-ischemic brain damage
Luyao Li, Zhen Lin, Junhui Yuan, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116941-116941
Closed Access | Times Cited: 38
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175300-175300
Closed Access | Times Cited: 34
Parkinson’s Disease: Exploring Different Animal Model Systems
Engila Khan, Ikramul Hasan, M. Emdadul Haque
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9088-9088
Open Access | Times Cited: 20
Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
Rohan Gupta, Dia Advani, Divya Yadav, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6476-6529
Closed Access | Times Cited: 20
Polyphenols: Natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective
Zhenmin Li, Ting Zhao, Mingqin Shi, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 18
First Insight into the Neuroprotective and Antibacterial Effects of Phlorotannins Isolated from the Cell Walls of Brown Algae Fucus vesiculosus and Pelvetia canaliculata
Darya A. Meshalkina, Elena Tsvetkova, Anastasia Orlova, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 696-696
Open Access | Times Cited: 14
Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
Ting He, Xiaoyan Lin, Anping Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Neurotrophic Natural Products
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2024), pp. 1-473
Closed Access | Times Cited: 5
Liraglutide and Naringenin relieve depressive symptoms in mice by enhancing Neurogenesis and reducing inflammation
Yara S. Abdelkawy, Mona Elharoun, Eman Sheta, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176525-176525
Closed Access | Times Cited: 5
Effectiveness of Flavonoid-Rich Diet in Alleviating Symptoms of Neurodegenerative Diseases
Aneta Szulc, Karolina Wiśniewska, Magdalena Żabińska, et al.
Foods (2024) Vol. 13, Iss. 12, pp. 1931-1931
Open Access | Times Cited: 5
Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson’s Disease: Insights into Mechanisms and Pathological Consequences
Sandeep XXXX, Mir Hilal Ahmad, Linchi Rani, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4466-4487
Closed Access | Times Cited: 17
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Yueli Zhu, Xiaoming Guo, Shumin Li, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
Sanjay Sanjay, Anshul Sharma, Hae‐Jeung Lee
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1914-1914
Open Access | Times Cited: 22
Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)
Sukhwinder Singh, Shivani Chib, Md Jawaid Akhtar, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 992-1015
Open Access | Times Cited: 8
Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model
Mehmet Enes Arslan, Hasan Türkez, Yasemin Sevim, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 992-992
Open Access | Times Cited: 8
Paraquat-induced neurogenesis abnormalities via Drp1-mediated mitochondrial fission
Bing Zhang, Yuwei Zhang, Zhenzi Zuo, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 257, pp. 114939-114939
Open Access | Times Cited: 8
Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP+/MPTP-Induced Dysregulation of Dopaminergic Regulatory Mechanisms in SH-SY5Y Cells and a Mouse Model of Parkinson’s Disease
Linchi Rani, Balaram Ghosh, Mir Hilal Ahmad, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4693-4715
Open Access | Times Cited: 8
Amelioration of Amyloid‐β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK‐3β/Wnt/β‐Catenin Signaling
Sushma, Manas Ranjan Sahu, N. Arul Murugan, et al.
Molecular Nutrition & Food Research (2023) Vol. 68, Iss. 13
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top